| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |